Latest Options News

Southern Palladium’s Optimised Prefeasibility Study reveals a $857 million project valuation and a 38% cut in peak capital expenditure through a staged development plan for its Bengwenyama PGM project in South Africa.

Sarama Resources has successfully closed the first tranche of a A$2.7 million equity placement to fund exploration at its Cosmo Gold Project and support ongoing arbitration efforts. The second tranche, involving options and director participation, awaits shareholder approval.

Bryah Resources has signed a binding option to acquire the high-grade Golden Pike gold project in Canada, while appointing Greg Hill as its new CEO to steer exploration and development efforts.

Zenith Minerals has successfully raised A$3.5 million through a fully underwritten rights issue, positioning the company to fast-track exploration and resource growth at its key gold projects in Western Australia and Queensland.

InteliCare Holdings has raised $1 million through a structured financing deal to extend its cash runway and scale its AI-driven healthcare platform across aged care and disability sectors.

Telix Pharmaceuticals has achieved a key milestone with its next-generation prostate cancer imaging agent, Gozellix, receiving a permanent HCPCS code from U.S. Medicare. This paves the way for broader reimbursement and market adoption starting October 2025.

Mithril Silver and Gold Limited has announced a C$10 million brokered private placement to fund expanded exploration at its Copalquin district project in Mexico. The raise includes an option for agents to increase the placement by 15%, underscoring strong investor interest.

Island Pharmaceuticals has accelerated its acquisition of the Galidesivir antiviral program from BioCryst Pharmaceuticals, adding a clinically advanced asset with significant US government backing and a promising regulatory pathway.

Blackstone Minerals has revealed significant surface copper and gold mineralisation adjacent to its flagship Mankayan project in the Philippines, setting the stage for expanded exploration and development.

Siren Gold reveals promising expansion and development prospects at its Sams Creek Project in New Zealand, with recent drilling uncovering new mineralised zones and a mining permit decision expected by year-end.

Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.

Winsome Resources has resumed targeted exploration for high-grade cesium mineralisation at its Sirmac-Clapier Project in Quebec, aiming to define drill targets following promising 2024 results.